The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Naropin 10 mg/ml solution for injection

Aspen Pharma Trading LimitedPA1691/026/003

Main Information

Trade NameNaropin 10 mg/ml solution for injection
Active SubstancesRopivacaine Hydrochloride
Dosage FormSolution for injection
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/026/003

Group Information

ATC CodeN01BB Amides
N01BB09 ropivacaine


License statusAuthorised
Licence Issued26/06/1996
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back